← All organizations

Concert Pharmaceuticals

For profitWebsite ↗

Also known as: Concert Pharmaceuticals | Concert Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 11, 2022

Acquired by Sun Pharmaceuticals

Timeline

2000s

Jun 1, 2006
Concert Pharmaceuticals— Founded

Drugs by trial phase (17 distinct, 36 trials)

Phase 3 (1 own, 0 via acquisition)

deuruxolitinib

Phase 2 (4 own, 0 via acquisition)

Phase 1 (12 own, 0 via acquisition)

Indications

Studied for

Recent trials (50)

NCT05478772Lead sponsorPhase 1Jul 11, 2022
NCT05467709Lead sponsorPhase 1Jun 21, 2022
NCT05467696Lead sponsorPhase 1Jun 14, 2022
NCT05468749Lead sponsorPhase 1Jun 6, 2022
NCT05467722Lead sponsorPhase 1Jun 1, 2022
NCT05192369Lead sponsorPhase 1Jan 4, 2022
NCT05041803Lead sponsorPhase 3Oct 19, 2021
NCT04797650Lead sponsorPhase 3May 27, 2021
NCT04843540Lead sponsorPhase 1May 19, 2021
NCT04743414Lead sponsorPhase 1Mar 2, 2021
NCT04784533Lead sponsorPhase 2Feb 26, 2021
NCT04518995Lead sponsorPhase 3Nov 2, 2020
NCT04309643Lead sponsorPhase 1Apr 30, 2020
NCT04158687Lead sponsorPhase 2Nov 26, 2019
NCT04092712Lead sponsorPhase 1Sep 5, 2019

Details

Founded: Lexington, MA, US Jun 1, 2006
Last known activity: Jul 11, 2022